Physician profile
Randall C Marsh
NPI 1720042161
$1,466.77
in general payments reported to CMS, 2019-2025
18 companies · $69.46 in 2025
The $69.46 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $34.28 · 2021: $309 · 2022: $304 · 2023: $189 · 2024: $351 · 2025: $69.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $235.77 | 2019-2022 | |
| Pfizer INC. | $217.55 | 2019-2025 | |
| Boston Scientific Corporation | $147.06 | 2023-2024 | Watchman Access System |
| Heartflow, INC. | $145.32 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $139.75 | 2021-2022 | |
| Novo Nordisk INC | $97.98 | 2024 | |
| Novartis Pharmaceuticals Corporation | $95.05 | 2019-2025 | |
| Amgen INC. | $76.51 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $75.77 | 2022-2024 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $49.26 | 2021-2024 | Andexxa, Farxiga |
| Abiomed | $33.75 | 2023 | Impella |
| Philips North America LLC | $32.88 | 2023-2024 | (Ck4) Mcot |
| Edwards Lifesciences Corporation | $25.54 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.84 | 2025 | |
| Janssen Pharmaceuticals, INC | $21.79 | 2023 | Xarelto |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $18.49 | 2021 | |
| Biotronik INC. | $15.70 | 2022 | |
| Medtronic, INC. | $14.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Marsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.